Skip to main content
Clinical Trials/KCT0007245
KCT0007245
Recruiting
未知

Comparison of the incidence of delirium after transfemoral transcatheter aortic valve replacement under monitored anesthesia care with remimazolam versus dexmedetomidine

Asan Medical Center0 sites186 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Asan Medical Center
Enrollment
186
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 65 years of age or older who are scheduled to receive transfemoral TAVI under monitored anesthesia care

Exclusion Criteria

  • ?. Patients scheduled for general anesthesia during TAVI
  • ?. Patients undergoing TAVI by a technique other than transfemoral TAVI (e.g., transapical TAVI, transcarotid TAVI, transaortic TAVI, etc.).
  • ?. Patients with preoperative delirium
  • ?. Patients receiving circulatory support before surgery, such as vasopressors, inotropes, and ECMO
  • ?. Patients who have a history of allergy to dexmedetomidine, opioids, or benzodiazepines
  • ?. Patients who are contraindicated to the use of dexmedetomidine, remimazolam, or remifentanil
  • ?. End\-stage renal failure patients receiving dialysis
  • ?. Child\-Pugh class C liver cirrhosis
  • ?. Patients deemed unsuitable for the study for other reasons by the researcher

Outcomes

Primary Outcomes

Not specified

Similar Trials